Nice 4c, progressing well margin above my base case of 50% , but YOY sales growth below my base case of 30% growth. CR already flagged by management and coming end of CY though expecting CR at 50c after FDA approval but time will tell. IMO. GLTAH.
Nice 4c, progressing well margin above my base case of 50% , but...
Add to My Watchlist
What is My Watchlist?